x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

OncoPharm

OncoPharm is a podcast dedicated to all things oncology pharmacy. Most episodes cover updates and recent publications concerning the use of medications in caring for patients with cancer. Periodically, episodes drop devoted to Landmark Clinical Trials in oncology and Fundamentals of Oncology Pharmacy.

science

All Episodes

00:18:20

Duvelisib

OncoPharm ·

2018/09/26

The latest #oncopharm approval for duvelisib is discussed as well as the similarities and differences to other PI3K inhibitors previously approved.

en

00:12:04

The Pseudomonas Exotoxin Drug

OncoPharm ·

2018/09/20

Discussing the new pseudomonas exotoxin drug (moxetumomab pasudotox-tdfk) for Hairy Cell Leukemia (3rd line). Lots of supportive care measures required, surprisingly, for the pseudomonas exotoxin drug.

en

00:16:21

*Bonus Pod* World Marrow Donor Day '18

OncoPharm ·

2018/09/15

Celebrating World Marrow Donor Day by recapping the HSCT donation experience of your favorite podcast host.

en

00:18:17

5-Fluorouracil

OncoPharm ·

2018/09/14

5-FU: both its mechanisms, all its toxicities, most of its uses, and some of its history are discussed.

en

00:22:29

Ask OncoPharm (Part 1) & RELEVANCE

OncoPharm ·

2018/09/06

The debut of our mailbag (Ask OncoPharm) to give some tips to new oncology pharmacists. Then (13:10) we review the RELEVANCE study of rituximab/lenalidomide in follicular lymphoma.

en

00:28:42

Influenza Vaccination during Chemo

OncoPharm ·

2018/08/30

It's flu shot season, so we're taking a pseudo-systematic review of influenza vaccination in patient receiving chemotherapy. Questions addressed include: How effective is influenza vaccination for cancer patients? What's the optimal timing of vaccination during chemo?

en

00:23:46

Small Cell Lung Cancer: Established & Recent Advances

OncoPharm ·

2018/08/23

Small cell lung cancer is reviewed, including the milestone advances (chemo + RT, omitting surgery, cis/etoposide) of the past leading up to the latest advance (15:20) - FDA-approval of nivolumab in the 3rd-line setting.

en

00:13:38

Mogamulizumab & August updates

OncoPharm ·

2018/08/16

Mogamulizumab-kpkc (MOAs, administration, toxicity) and its FDA-approval is discussed followed by (9:00) updates lenvatinib (a good update) and azithromycin (a bad update) in cancer patients.

en

00:18:34

Rituximab

OncoPharm ·

2018/08/09

We explore the origins of rituximab's dose, geek out on the NNT in DLBC, and discuss other "need to know" tidbits.

en

00:13:19

Iobenguane I-131 & Lusutrombopag

OncoPharm ·

2018/08/02

Catching up the recent FDA-approvals for iobenguane I-131 (and its myriad of precautions) and lusutrombopag.

en

00:13:27

Ivosidenib

OncoPharm ·

2018/07/26

After running through recent FDA updates (including ribociclib's approval in PRE-menopausal breast cancer patients), the newly approved ivosidenib is discussed.

en

00:14:39

A Brief History of Pemetrexed

OncoPharm ·

2018/07/20

Ten years ago a preplanned subgroup analysis changed the NSCLC treatment algorithms. We go back to the beginning with pemetrexed and the studies leading up to the oft-cited Scagliotti that ushered in histology-specific treatment in NSCLC.

en

00:16:59

Paclitaxel

OncoPharm ·

2018/07/11

We discuss paclitaxel, from its discovery to its uses to toxicity and their management as part of our Landmarks in #OncoPharm series. And if you really, really love this drug - you'll learn where to may homage at a historical marker in....

en

00:07:13

Happy Fourth!

OncoPharm ·

2018/07/04

Our shortest Pod yet! Chemotherapy explosions and photosensitizing antineoplastics are discussed.

en

00:17:41

Encorafenib & Binimetinib

OncoPharm ·

2018/06/28

The newly FDA-approved BRAF & MEK inhibitors are discussed, along with their possible clinical relevance and some notable differences compared to previously available BRAF & MEK inhibitors.

en

00:18:00

The Immunotherapy Two Step

OncoPharm ·

2018/06/21

Immunotherapy takes two steps forward (new FDA approvals)....and two steps backwards. These updates in #oncopharm are discussed before ending (11:45) with discussions of venetoclax's expanded approval in CLL, the bevacizumab approval almost 7 years in the making, and late-breaking information on preventing cisplatin ototoxicity.

en

00:15:56

Ondansetron Origins

OncoPharm ·

2018/06/13

The Landmarks in Oncology Pharmacy series returns with a review of 2 ondansetron studies from 1990, published simultaneously in NEJM.

en

00:24:02

Less is More & More

OncoPharm ·

2018/06/07

Recapping (some) of the top stories from ASCO18 starting with breast cancer (TAILOR-Rx, PERSEPHONE, SANDPIPER, S0927); then NSCLC (11:35) with Keynote-42 & LOXO-292; then mylemoa (16:50) with a CAR-T update and a new dosing of carfilzomib; before ending (20:30) with CARMENA and PRODIGY-24's new mFOLFIRINOX data for adjuvant pancreatic cancer. Whew!

en

00:15:52

ASCO18 & Under the Radar Abstracts

OncoPharm ·

2018/05/31

Previewing this week's ASCO annual meeting and the Plenary Sessions (briefly) and selected abstracts highlighting oncology pharmacy practice.

en

00:17:20

Avatrombopag

OncoPharm ·

2018/05/25

Avatrombopag's FDA-approval prompts discussion of both the indication and drug itself. Finally, the publication of the SELECT-D study allows us to dig deeper into the data of a DOAC vs. LMWH in cancer-associated VTE.

en

424 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter